ABSTRACT
INTRODUCTION

28
Drug delivery (DD) has historically been pivotal in ensuring drugs can be administered in a 29 manner that leads to therapeutic efficacy. Methods of DD, such as oral ingestion or hypodermic
30
injections are considered to be the most common forms of drug administration [1, 2] . However,
31
they possess several limitations, e.g., pain associated with hypodermic injections due to the 32 long needles piercing nerve endings and absorption and metabolism issues associated with 33 oral administration that lead to variability in bioavailability and also side effects from metabolites 34 [3] . These disadvantages have led to the development of alternative DD methods. An encouraging alternative to the traditional methods is DD directly through the skin surface, i.e., which provide controlled release of medicines to patients in a minimally invasive manner. currently incomplete, therefore the analysis will give an indication of the trend till 2013 [51] . For the completeness of the paper, we discuss other relevant issues as well as follows.
Why microneedles?
111
TDPs have been delivering a variety of drugs since the early 1980's such as testosterone,
112
nicotine, Selegiline and Clonidine [33] . Although there are several commercially available TDPs administer drugs via passive diffusion as illustrated in Figure 1a [52] . There are two 115 mechanisms for the storage of drugs on TDPs. A drug is either stored in a reservoir or 116 incorporated into the transdermal patch fabric, whereby it is transported across the skin via a 117 concentration gradient [13] . Although these methods have shown to be applicable for a variety 118 of drug formulations, they are still limited by the drug molecules that can permeate through the 119 SC barrier. As mentioned earlier, MNs have been proposed as an alternative delivery method
120
to TDPs and hypodermic syringes as they have shown to overcome the various short comings 121 previously outlined. Indeed, it has been illustrated by Benson and Namjoshi [4] and many other 122 researchers [52] [53] [54] that MN research is a promising field of research to be pursued more 123 extensively as it can be used to overcome the skin's natural defensive barrier, the SC in both 124 adults and children. The rate of release of the drug depends upon the controlling membrane of method. Furthermore, there are initial challenges to overcome, such as the low permeability of
Skin
is the largest organ in the human anatomy with an approximate surface area of 20,000 cm 2 on 147 an average human male, which spans the entire external surface of the body [70] , in which its 148 main function is to contain all the internal organs, protect them against foreign organisms and
149
bacteria and act as a passive barrier. Some of the skin's other functions include the regulation
150
of internal body temperature, insulation, resistance against foreign bacteria and to provide 151 protection to the internal organs [71] . The surface area of the skin constantly changes 152 depending on age, weight loss and gain, [72, 73] height and sex of a human being [74] . It is 153 also a receptive organ to thermal heat and pain. The skin comprises of several layers of which
154
the main layers consist of the epidermis, dermis and subcutaneous tissue [71] , see Figure 1 .
155
The figure illustrates the SC, a non-living layer, which provides the first barrier to foreign bodies
156
and DD. Below the SC layer is the epidermis containing living tissue with no blood vessels.
thickness of skin is vastly variable due to a number of factors. These include, the race, sex, and
170
age of a person and also on different areas of the body. It has also been shown that aging and 171 diabetes have an effect on skin thickness [72] . In particular it was found that subcutaneous fat 172 thickness in different body regions was thinnner in aging skin and in diabetic patients. A reduction in the skin thickness of the hand was also observed for diabetic patients. Therefore, consideration of skin thickness would need to be examined when choosing an active site for Figure 1 Cross section through human skin a: intracellular, b: hair follicles and sweat glands, c:
Understanding the mechanical properties of skin and detailed knowledge on various skin layers 182 [76] are important as the insertion of needles into the skin would alter the skins mechanical
183
response to all skin layers [77] . 
187
which a material can be located, the age of the patient, the thickness of the skin, orientation, etc. [76, [78] [79] [80] . It is a complex organ that continuously changes as we age [79] . A property of 189 skin that has been studied is the skin's ability to fold upon itself, such as wrinkling [81] . Smalls
190
et al. [76] investigated the body's biomechanical skin properties which showed a significant body. This was possibly the result of 90% of subjects being right handed, which illustrated that
193
an increase in muscle tone can also have an effect on the biomechanical skin properties. Cua
194
et al. [79] . concluded that the biomechanical properties of skin decreased with increasing age,
195
which may be due to natural degeneration as we get older. SC thickness on human forearm,
196
palm, cheek and lower leg were also studied to determine by using two non-invasive measuring
197
techneques namely, confocal Raman spectroscopy and confocal laser scanning microscopy, to 198 measure SC thickness which were then compared to the thickness in literature data. It was
199
found that it was possible to accurately measure the SC thickness with both techniques [82] .
200
Increasing Permeability of Skin
201
The use of MN as a drug delivery system is an important development as the potential to allow 202 a wider scope of molecules to be transdermally delivered through the skin is greatly increased [83] [84] [85] [86] . The amount of drug that is delivered can also be increased. However, an transdermally. However, the data published by Prausnitz et al. [33] illustrate that the use of
218
MNs is a promising technique as it possessed many of the required properties for the delivery 219 of drug therapeutics. Figure 1d depicts the micron sized holes that can be created by MNs upon 220 the skin.
221
There are several physical methods that have been used in conjunction with MN technology to
222
increase skin permeation [93] [94] [95] . One such example is the use of sonophoresis with MNs. It is 223 a technique which allows molecules to permeate through the barrier of the skin more readily as 224 ultrasonic waves create micro-vibrations on the skin [92] . Monomeric insulin analogues were 225 studied to investigate the rate of iontophoresis transport on mice skin [25] . The study showed
226
clinically relevant results for insulin regulation. 
234
MNs can be considered to be a micron scale hybrid between TDPs and hypodermic syringes,
235
to overcome limitations that are associated with the individual application. They are small arrays of needles that are generally less than 1 mm in length [104] [105] [106] [107] . There are multiple MN solid or hollow MNs [108] . The materials that have been used to fabricate them range from metal [109] , glass, silicon [110] and biodegradable polymers (polydimethylsiloxane) [111, 112] pharmaceutical ingredients, etc. [19] . Metals traditionally used for MN fabrication consist of 243 stainless steel, nickel coated in gold, titanium, platinum, palladium [47, 115, 116] . Although 244 numerous journal papers have been published on the use of silicon as a primary substituent of
245
MN formulation, the material itself has yet to be FDA approved [90] .
246
MNs provide a direct pathway for drugs to access the viable dermis, allowing for a painless DD
247
that by-passes the SC [4] . They also differ in shape, ranging from square, circular, flat tipped,
248
sharp tipped etc., [32, 90, [116] [117] [118] [119] [120] [121] . There has been a lot of research conducted on MNs for the 249 delivery and monitoring of various drugs such as glucose control for diabetics [61, 46, [122] [123] [124] [125] ,
250
Alzheimer's disease [110] , anti-cancer [126] and other conditions [127] . Measles was able to be coated and dried onto MN. Vaccine delivery into rats was comparable to using hypodermic needles which gave similar antibody tilters [63] associated with safety and disposal. They found that the use of biodegradable MNs increased 258 skin permeability by three fold which increase the delivery of drugs transdermally. Gupta et al.
259
[119] used hollow MNs for bolus deilvery of lispro insulin in comparison to catheter infusion.
260
They found that MNs inserted 1 mm into human skin showed rapid insulin absortption with no 261 pain observed from the volunteers in comparison to catheter infusion [131] .
262
A method to fabricate MNs is important, as desirable attributes would be to have a simplistic 263 fabrication method that is low cost and reproducible. This would be advantageous when mass
264
producing MNs for industrial application [132] . However, the delivery of drugs using MNs can
265
be conducted in four different ways. These can be known as "poke and patch", "coat and poke", 
270
The rate of the development in MN research has increased significantly since the first papers 
274
The forecast is shown in Figure 2 . Trends will also be determined for specific microneedle types 275 in the forthcoming sections in the paper. opposed to the tip for the delivery of drugs using a microfluidic liquid transfer. These were made and pitch 500 µm were produced.
316
ARIMA model has been applied to the 167 journal papers that have been found in the journal 317 data base Scopus with the search term "hollow microneedle" (Figure 3 ). It is obvious that the 318 fitted and the observed data do not match well which is due to the small number of publications
319
per year. This suggests that while the total numbers of publications relating to hollow 320 microneedles are increasing, the trend (e.g., the number of publications in different years)
321 cannot be reliably predicted. Nevertheless, the ARIMA model has been applied to predict the 
331
can produce micro pores in skin, which bypasses the SC layer, and allow drugs to permeate to 332 the viable epidermis [110] . There have been a number of methods and materials used to 333 fabricate solid MNs [139] [140], some of which are represented in Table 2 .
334
The first reported case of solid MNs in literature was in the study of gene therapy [141] .
transdermally Figure 4B ). This method of fabrication was shown to be laborious and 348 used a number of strong acids which could pose problems when disposing of such chemicals.
349
The application of this MN into hairless rats also required an external high velocity applicator to
350
successfully insert the MN into the skin. Although the MNs used to elucidate the transdermal
351
delivery of insulin produced successful data in reducing glucose levels by up to 80%, the 352 fabrication method would not be considered a simple process.
353
The fabrication of biodegradable and biocompatible polymers was proposed by Park et al. [90] 354 to address the issues associated with cost effective fabrication materials and problems
355
associated with MN fabrication materials, such as metal, a sharp hazardous waste, and silicon
356
which has yet to be FDA approved [90] . The material was considered to be a safer alternative
357
as it is mechanically strong and relativly inexpensive. 
360
solid microneedle next to a 27-gauge syringe [47] 361
As shown in Table 2 , silicon has been widely researched when developing MNs.
362
Polydimethylsiloxane was used by Chu and Prausnitz [111] to show the material combined the 363 mechanical strength that metal MNs can provide and the useful properties of silicon drug based 364 arrow head ( Figure 6 ). They showed that the production of a blunt metal shaft with a detachable
365
A B
drug encapsulated arrow head on the end could provide drug to the viable epidermis within 366 seconds to porcine and human cadaver skin.
367
There 
378
ARIMA model has been applied to the 112 journal papers that have been found using the [150] [151] [152] . Table 4 shows a summary of patents that have been taken out on materials to 437 fabricate MNs. Table 5 illustrates some example patents on the methods of MN fabrication.
438 Table 6 shows patents on chemicals used for MN transdermal delivery system. 
475
The use of time series analysis allows the extrapolation of trends in data to predict the 476 number of journal papers published. This can occur provided the number of data sets
477
(observations) is sufficient to produce a good estimate. In the case of microneedles, solid 478 and hollow, this was possible. However this was not sufficient for dissolvable microneedles.
479
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